Clinical Quality Oversight Forum

Call for Papers

ExL’s Clinical Quality Oversight Forum continues to live up to its reputation as an elite gathering of senior-level executives. A meaningful exchange of ideas results from the audience’s willingness to candidly share their experiences, productively discuss strategies for improving oversight, and engage with one another. This unique interactive atmosphere makes for a valuable conference experience, ensuring participants leave with new ideas, strategies and practical tools for optimizing clinical quality, and the connections necessary to execute them.

Prices:

Conference Only — Early Bird Pricing — Register by August 30, 2019: USD 1895.00,

Conference + 1 Workshops — Early Bird Pricing — Register by August 30, 2019: USD 2195.00,

Conference + 2 Workshops — Early Bird Pricing — Register by August 30, 2019: USD 2395.00,

Conference + Seminar — Early Bird Pricing — Register by August 30, 2019: USD 2395.00,

Conference Only — Standard Pricing — Register after August 30, 2019: USD 2095.00,

Conference + 1 Workshops — Standard Pricing — Register after August 30, 2019: USD 2395.00,

Conference + 2 Workshops — Standard Pricing — Register after August 30, 2019: USD 2595.00,

Conference + Seminar — Standard Pricing — Register after August 30, 2019: USD 2595.00

Time: 9:00 am - 5:00 pm

Speakers: Kristy Galante, M.S. Director External Alliances, Global Clinical Development Operations, JANSSEN RESEARCH AND DEVELOPMENT, LLC, Kenneth A. Getz, MBA Chairman, CISCRP Director of Sponsored Research, TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT, Sheila Gwizdak Principal Consultant , HALLORAN CONSULTING GROUP, Maryann Livolsi, MSN, RN Senior Director, GCP Quality Assurance, BILL AND MELINDA GATES MEDICAL RESEARCH INSTITUTE, Jonathan Rowe, Ph.D., M.S., M.A. Executive Director, Head of Clinical Development Quality Performance and Risk Management, PFIZER, Christine Sahagian Head of Registries and Late Phase QA and Compliance, SHIRE, Dennis Salotti, M.S., MBA, CCRA Chief Operating Officer, THE AVOCA GROUP, Stacy St. John Director, Clinical Development Quality – Vendor Quality and Quality Culture, PFIZER, Krista Tibbs Specialist, Clinical Development, HALLORAN CONSULTING GROUP, Michael Torok, Ph.D. Clinical Quality Assurance Head, ASTELLAS, Jane Wood Quality Center of Excellence Lead, YOUR ENCORE, Liz Wool President, WOOL CONSULTING GROUP, INC., Steve Young Chief Operations Officer, CLUEPOINTS